TY - JOUR
T1 - ACOG PRACTICE BULLETIN SUMMARY NUMBER 212 Pregnancy and Heart Disease
AU - Presidential Task Force on Pregnancy and Heart Disease
AU - Committee on Practice Bulletins–Obstetrics
AU - Hollier, Lisa M.
AU - Martin, James N.
AU - Connolly, Heidi
AU - Turrentine, Mark
AU - Hameed, Afshan
AU - Arendt, Katherine W.
AU - Cannon, Octavia
AU - Coleman, Lastascia
AU - Elkayam, Uri
AU - Gregg, Anthony
AU - Haddock, Alison
AU - Higgins, Stacy M.
AU - Kendig, Sue
AU - Liu, Robyn
AU - Martin, Stephanie R.
AU - McNamara, Dennis
AU - Nicholson, Wanda
AU - Ramsey, Patrick S.
AU - Riley, Laura
AU - Rochin, Elizabeth
AU - Rosen, Stacey E.
AU - Sinkey, Rachel G.
AU - Smith, Graeme
AU - Tibbs, Calondra
AU - Tsigas, Eleni Z.
AU - Villanueva, Rachel
AU - Wei, Janet
AU - Zelop, Carolyn
N1 - Publisher Copyright:
© 2019 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc.
PY - 2019/5
Y1 - 2019/5
N2 - Maternal heart disease has emerged as a major threat to safe motherhood and women’s long-term cardiovascular health. In the United States, disease and dysfunction of the heart and vascular system as “cardiovascular disease” is now the leading cause of death in pregnant women and women in the postpartum period (1, 2) accounting for 4.23 deaths per 100,000 live births, a rate almost twice that of the United Kingdom (3, 4). The most recent data indicate that cardiovascular diseases constitute 26.5% of U.S. pregnancy-related deaths (5). Of further concern are the disparities in cardiovascular disease outcomes, with higher rates of morbidity and mortality among nonwhite and lower-income women. Contributing factors include barriers to prepregnancy cardiovascular disease assessment, missed opportunities to identify cardiovascular disease risk factors during prenatal care, gaps in high-risk intrapartum care, and delays in recognition of cardiovascular disease symptoms during the puerperium. The purpose of this document is to 1) describe the prevalence and effect of heart disease among pregnant and postpartum women; 2) provide guidance for early antepartum and postpartum risk factor identification and modification; 3) outline common cardiovascular disorders that cause morbidity and mortality during pregnancy and the puerperium; 4) describe recommendations for care for pregnant and postpartum women with preexisting or new-onset acquired heart disease; and 5) present a comprehensive interpregnancy care plan for women with heart disease.
AB - Maternal heart disease has emerged as a major threat to safe motherhood and women’s long-term cardiovascular health. In the United States, disease and dysfunction of the heart and vascular system as “cardiovascular disease” is now the leading cause of death in pregnant women and women in the postpartum period (1, 2) accounting for 4.23 deaths per 100,000 live births, a rate almost twice that of the United Kingdom (3, 4). The most recent data indicate that cardiovascular diseases constitute 26.5% of U.S. pregnancy-related deaths (5). Of further concern are the disparities in cardiovascular disease outcomes, with higher rates of morbidity and mortality among nonwhite and lower-income women. Contributing factors include barriers to prepregnancy cardiovascular disease assessment, missed opportunities to identify cardiovascular disease risk factors during prenatal care, gaps in high-risk intrapartum care, and delays in recognition of cardiovascular disease symptoms during the puerperium. The purpose of this document is to 1) describe the prevalence and effect of heart disease among pregnant and postpartum women; 2) provide guidance for early antepartum and postpartum risk factor identification and modification; 3) outline common cardiovascular disorders that cause morbidity and mortality during pregnancy and the puerperium; 4) describe recommendations for care for pregnant and postpartum women with preexisting or new-onset acquired heart disease; and 5) present a comprehensive interpregnancy care plan for women with heart disease.
UR - http://www.scopus.com/inward/record.url?scp=85065302721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065302721&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000003244
DO - 10.1097/AOG.0000000000003244
M3 - Article
C2 - 31022119
AN - SCOPUS:85065302721
SN - 0029-7844
VL - 133
SP - 1067
EP - 1072
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 5
ER -